234 related articles for article (PubMed ID: 33058474)
1. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
[TBL] [Abstract][Full Text] [Related]
2. Biological stratification of clinical disease courses in childhood immune thrombocytopenia.
Schmidt DE; Heitink-Pollé KMJ; Mertens B; Porcelijn L; Kapur R; van der Schoot CE; Vidarsson G; van der Bom JG; Bruin MCA; de Haas M
J Thromb Haemost; 2021 Apr; 19(4):1071-1081. PubMed ID: 33386662
[TBL] [Abstract][Full Text] [Related]
3. Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.
Schmidt DE; Heitink-Pollé KMJ; Laarhoven AG; Bruin MCA; Veldhuisen B; Nagelkerke SQ; Kuijpers TW; Porcelijn L; van der Schoot CE; Vidarsson G; de Haas M
Blood Adv; 2019 Jul; 3(13):2003-2012. PubMed ID: 31270082
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
5. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
7. [Influencing Factors in the Chronicity of Immune Thrombocytopenia in Children].
Wang LY; Liu KK; Chu JH; Yang LH; Xie ZW; Zhang KL; Chai HJ; Wu ZY; Wang NL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):881-886. PubMed ID: 34105488
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
Kjaersgaard M; Edslev PW; Rosthøj S
Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
[TBL] [Abstract][Full Text] [Related]
9. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453897
[TBL] [Abstract][Full Text] [Related]
11. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
Neunert C; Heitink-Polle KMJ; Lambert MP
Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
[TBL] [Abstract][Full Text] [Related]
12. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications.
Schmidt DE; Heitink-Polle KMJ; Porcelijn L; van der Schoot CE; Vidarsson G; Bruin MCA; de Haas M
J Thromb Haemost; 2020 May; 18(5):1210-1220. PubMed ID: 32053276
[TBL] [Abstract][Full Text] [Related]
16. Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.
Choi HS; Ji MH; Kim SJ; Ahn HS
Blood Res; 2016 Jun; 51(2):95-101. PubMed ID: 27382553
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins ameliorate thrombin-related platelet functions in childhood immune thrombocytopenia.
Kapur R
Br J Haematol; 2023 Jun; 201(6):1019-1020. PubMed ID: 36924289
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
